Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation

Daniela Marasco1, Romania Stilo, Annamaria Sandomenico

  • 1Istituto di Biostrutture e Bioimmagini (IBB), CNR, 80134, Napoli, Italy.

Insights

Researchers identified a BCL10 peptide (residues 91-98) that inhibits self-association and blocks NF-kappaB activation. This finding offers potential therapeutic strategies for diseases linked to aberrant NF-kappaB signaling.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Immunology

Background:

  • The BCL10-CARMA protein complex is crucial for NF-kappaB transcription factor activation.
  • Complex assembly involves homophilic interactions between CARD domains of BCL10 and CARMA proteins.

Purpose of the Study:

  • To identify BCL10-inhibitory peptides.
  • To investigate the role of BCL10 self-association in NF-kappaB signaling.

Main Methods:

  • Developed an assay for BCL10 CARD peptides in CARD-CARD self-association binding competition.
  • Screened BCL10-derived peptides to identify inhibitors of protein self-association.
  • Tested the inhibitory peptide in cell assays for NF-kappaB activation.

Main Results:

  • A peptide (residues 91-98) effectively inhibited BCL10 self-association.
  • This peptide repressed NF-kappaB activation mediated by BCL10, CARMA3, and PMA/ionomycin.
  • Residues 91-98 of BCL10 are involved in self-association and interactions with other partners.

Conclusions:

  • The BCL10 CARD peptide (91-98) is a potent inhibitor of BCL10 self-association.
  • Blocking BCL10 CARD interactions may offer a therapeutic approach for conditions with inappropriate NF-kappaB activation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...